Skip to main content
NVDA-0.13%AAPL+1.07%GOOGL-2.28%MSFT+0.05%AMZN-0.04%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.80%TSLA-0.43%SKHY+7.05%MU-1.26%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.38%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.52%0005.HK-0.78%HSBA.L-1.53%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.23%CHFJPY-1.75%USDJPY-1.65%AUDJPY-1.56%EURJPY-1.47%CADJPY-1.46%GBPJPY-1.41%GBPNZD+0.82%EURNZD+0.79%NZDCAD-0.79%AUDNZD+0.70%NZDUSD-0.61%NZDCHF-0.50%GBPTRY+0.41%GBPCHF+0.33%GBPHKD+0.32%GBPMXN-0.28%CADCHF+0.28%EURCHF+0.28%GBPUSD+0.24%EURNOK+0.22%USDNOK+0.21%AUDCHF+0.20%EURZAR+0.20%GBPZAR+0.19%NZDSGD+0.19%USDZAR+0.19%USDCAD-0.17%EURUSD+0.17%USDILS+0.16%CHFNOK+0.15%NZDMXN+0.15%NOKJPY-0.13%GBPAUD+0.12%AUDCAD-0.12%USDTHB+0.12%USDCHF+0.11%USDTRY+0.11%AUDDKK-0.11%AUDNOK+0.11%AUDUSD+0.09%EURCZK-0.09%EURAUD+0.08%EURSGD+0.07%USDSGD+0.07%USDPLN+0.07%GBPSGD+0.07%EURPLN+0.07%EURSEK+0.05%USDMXN+0.05%USDSEK+0.04%EURGBP-0.04%USDCOP-0.04%AUDSGD-0.04%USDCNH-0.03%GBPCAD+0.03%PLNJPY+0.02%CHFSEK-0.02%EURCAD-0.01%SGDJPY+0.01%USDHKD+0.01%CHFSGD+0.01%EURCNH-0.01%EURHKD-0.01%EURDKK0.00%USDDKK0.00%COFFEE-2.20%SUGAR+1.96%XPTUSD-1.60%COTTON+1.41%GAGUSD-0.93%XAGUSD-0.93%COCOA-0.74%USOIL+0.68%S1+0.59%C1+0.52%UKOIL+0.47%HG1-0.38%BTCUSD-0.40%ETHUSD+0.11%USDTUSD-0.03%XRPUSD-1.20%SOLUSD-0.37%TRXUSDT+0.39%ZECUSDT-1.66%DOGEUSD-1.39%XMRUSDT-0.81%LINKUSD-0.02%XLMUSD-0.97%BCHUSDT-1.73%LTCUSD-1.51%UNIUSD-1.99%TONUSD+24.88%HBARUSDT-1.20%SUIUSD-1.19%TAOUSDT-0.84%AAVEUSD-1.48%DOTUSDT-2.09%ICPUSDT-1.01%ONDOUSDT-1.87%WLDUSDT-1.71%ATOMUSDT-2.11%ARBUSDT-0.18%JUPUSDT-2.53%INJUSDT-2.55%STXUSDT-2.70%FETUSDT-2.09%TIAUSDT-0.60%SEIUSDT-1.80%PYTHUSDT-1.11%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.01%OPUSDT-1.99%POLUSDT-3.13%IOTAUSDT-2.34%AXSUSDT-1.82%FARTCOINUSDT-1.40%EOSUSDT+0.12%DYDXUSDT-0.37%ORDIUSDT+0.74%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.13%AAPL+1.07%GOOGL-2.28%MSFT+0.05%AMZN-0.04%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.80%TSLA-0.43%SKHY+7.05%MU-1.26%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.38%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.52%0005.HK-0.78%HSBA.L-1.53%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.23%CHFJPY-1.75%USDJPY-1.65%AUDJPY-1.56%EURJPY-1.47%CADJPY-1.46%GBPJPY-1.41%GBPNZD+0.82%EURNZD+0.79%NZDCAD-0.79%AUDNZD+0.70%NZDUSD-0.61%NZDCHF-0.50%GBPTRY+0.41%GBPCHF+0.33%GBPHKD+0.32%GBPMXN-0.28%CADCHF+0.28%EURCHF+0.28%GBPUSD+0.24%EURNOK+0.22%USDNOK+0.21%AUDCHF+0.20%EURZAR+0.20%GBPZAR+0.19%NZDSGD+0.19%USDZAR+0.19%USDCAD-0.17%EURUSD+0.17%USDILS+0.16%CHFNOK+0.15%NZDMXN+0.15%NOKJPY-0.13%GBPAUD+0.12%AUDCAD-0.12%USDTHB+0.12%USDCHF+0.11%USDTRY+0.11%AUDDKK-0.11%AUDNOK+0.11%AUDUSD+0.09%EURCZK-0.09%EURAUD+0.08%EURSGD+0.07%USDSGD+0.07%USDPLN+0.07%GBPSGD+0.07%EURPLN+0.07%EURSEK+0.05%USDMXN+0.05%USDSEK+0.04%EURGBP-0.04%USDCOP-0.04%AUDSGD-0.04%USDCNH-0.03%GBPCAD+0.03%PLNJPY+0.02%CHFSEK-0.02%EURCAD-0.01%SGDJPY+0.01%USDHKD+0.01%CHFSGD+0.01%EURCNH-0.01%EURHKD-0.01%EURDKK0.00%USDDKK0.00%COFFEE-2.20%SUGAR+1.96%XPTUSD-1.60%COTTON+1.41%GAGUSD-0.93%XAGUSD-0.93%COCOA-0.74%USOIL+0.68%S1+0.59%C1+0.52%UKOIL+0.47%HG1-0.38%BTCUSD-0.40%ETHUSD+0.11%USDTUSD-0.03%XRPUSD-1.20%SOLUSD-0.37%TRXUSDT+0.39%ZECUSDT-1.66%DOGEUSD-1.39%XMRUSDT-0.81%LINKUSD-0.02%XLMUSD-0.97%BCHUSDT-1.73%LTCUSD-1.51%UNIUSD-1.99%TONUSD+24.88%HBARUSDT-1.20%SUIUSD-1.19%TAOUSDT-0.84%AAVEUSD-1.48%DOTUSDT-2.09%ICPUSDT-1.01%ONDOUSDT-1.87%WLDUSDT-1.71%ATOMUSDT-2.11%ARBUSDT-0.18%JUPUSDT-2.53%INJUSDT-2.55%STXUSDT-2.70%FETUSDT-2.09%TIAUSDT-0.60%SEIUSDT-1.80%PYTHUSDT-1.11%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.01%OPUSDT-1.99%POLUSDT-3.13%IOTAUSDT-2.34%AXSUSDT-1.82%FARTCOINUSDT-1.40%EOSUSDT+0.12%DYDXUSDT-0.37%ORDIUSDT+0.74%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%
PR

Precigen, Inc. (PGEN)

NASDAQ • Healthcare

$6.8
-$0.07 (-1.0%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$6.87
Day Range$6.68 - $6.89
Avg. Volume (3M)4.6M
Market Cap$2.4B
52 Week Range
$2.99$7.72
Next EarningsIn 63 daysNov 12, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$54.9M100%
Gross Profitminus cost of goods$52.1M95%
Operating Incomeminus R&D and overhead$22.6M41%
Net Incomeminus taxes and the rest$20M37%

In plain terms: out of every $100 in revenue, Precigen, Inc. keeps $37 as net profit.

Fundamentals & Financials

Revenue (TTM)
$85.7M
Net Income (TTM)
-$157.7M
EPS (TTM)
-$1.13
ROA (TTM)
-92.61%
Current Ratio
4.58
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+33.6%Q1 2026-$0.07
+33.3%Q2 2026-$0.02
+514.3%Q3 2026$0.05
Next

Nov 12

in 63 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +514.3%

Precigen’s results for the second fiscal quarter of 2026 pointed to cash outflow and a small share repurchase, with next-period consensus calling for EPS of $0.09 on revenue of $69.2 million; the company reported the quarter on August 4, 2026. During the period, operating cash flow was negative at roughly $17.8 million, reflecting a net cash use from operations. The company also repurchased about $1.5 million of stock. Precigen operates across human therapeutics and enabling technologies, including platforms such as UltraVector, RheoSwitch, and ActoBiotics, alongside regenerative-medicine and reproductive-tool offerings such as genetically engineered swine and reproductive and embryo transfer technologies.

View full earnings history

About Precigen, Inc.

Precigen, Inc. is a small-cap Biotechnology company listed on the NASDAQ under the ticker PGEN. The company develops disease-modifying treatments and applies its platform technologies to regenerative medicine and reproductive tools, with operations rooted in a business founded in 1998 and based in Germantown, Maryland.

Name
Precigen, Inc.
CEO
Helen Sabzevari
Website
www.precigen.com
Industry
Healthcare
Year Founded
1998
Employees
160

Today's Snapshot

AI-generated

The day ended with PGEN 1% lower at 6.80, while its sector was flat.

Trading Volume

Below 10d avg (3.5M)

3M

vs S&P 500 Today

Underperforming Market

-0.60%

Updated: September 9, 2026 at 20:12 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
PGEN shows a cautious buy stance underpinned by stronger long-term averages while near-term measures lag. The quote remains well above its 50–200 period averages but below short-term moving averages, and momentum indicators are mostly neutral with RSI around midrange and MACD near flat, indicating little momentum conviction. ADX signals only a modest trend, volatility is elevated with ATR around 5% and OBV is soft, which tempers enthusiasm. Technical takeaway: modest buy bias but short-term pressure and weak volume suggest limited upside conviction.
All signals
  • EMA (5 indicators)$4.97 - $6.98
    Buy
  • RSI (14)50.93
    Neutral
  • Stochastic %K (14, 3, 3)32.35
    Neutral
  • MACD Level (12, 26)0.19
    Neutral

Peers & Related Assets

DNTHDianthus Therapeutics, Inc.
$107.04-1.9%
ELVNEnliven Therapeutics, Inc.
$57.45-3.2%
RLAYRelay Therapeutics, Inc.
$18.66-2.4%
AMLXAmylyx Pharmaceuticals, Inc.
$32.4-4.4%
ORICORIC Pharmaceuticals, Inc.
$12.5-0.9%
WVEWave Life Sciences Ltd.
$4.81-2.0%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.